Related Experiment Video
Updated: Jun 5, 2025

09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
12.0K
Epidemiology, Pathophysiology, and Management of Cancer-Associated Ischemic Stroke
Dylan Ryan1, Tarek Bou Dargham2, Salman Ikramuddin3
1Department of Neurology, Duke University School of Medicine, Durham, NC 27704, USA.
Cancers
|December 17, 2024
Summary
Cancer-associated ischemic stroke is a unique subtype of stroke. This review details its epidemiology, mechanisms, and management, highlighting the need for specific guidance for these patients.
Area of Science:
- Oncology
- Neurology
- Cardiovascular Medicine
Background:
- Cancer and stroke are leading global causes of mortality and disability.
- Increasing survival rates in cancer patients lead to more cases of concurrent ischemic stroke and active malignancy.
- Cancer-associated ischemic stroke represents a distinct clinical entity requiring specialized care.
Purpose of the Study:
- To provide a comprehensive overview of cancer-associated ischemic stroke.
- To delineate the epidemiology, pathophysiology, and management strategies.
- To identify future research directions for this patient population.
Main Methods:
- This study is a narrative review.
- Literature search on cancer-associated ischemic stroke, focusing on epidemiology, pathophysiology, diagnosis, treatment, and rehabilitation.
- Synthesis of existing evidence to guide clinical practice and research.
Main Results:
- Cancer-associated ischemic stroke exhibits unique epidemiological and pathophysiological characteristics.
- Current management guidelines are limited, necessitating tailored approaches.
- There is a critical need for further research to optimize secondary prevention and rehabilitation.
Conclusions:
- Cancer-associated ischemic stroke is an emerging clinical challenge.
- A multidisciplinary approach is essential for effective management.
- Further investigation is crucial to improve outcomes for cancer patients experiencing stroke.
Related Concept Videos
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Cancer Prevention
6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.0K
Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
Ischemic Heart Disease: Overview
1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K

